Cargando…

Vimentin as a target for the treatment of COVID-19

We and others propose vimentin as a possible cellular target for the treatment of COVID-19. This innovative idea is so recent that it requires further attention and debate. The significant role played by vimentin in virus-induced infection however is well established: (1) vimentin has been reported...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhenlin, Paulin, Denise, Lacolley, Patrick, Coletti, Dario, Agbulut, Onnik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Respiratory Infection
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482103/ https://www.ncbi.nlm.nih.gov/pubmed/32913008 http://dx.doi.org/10.1136/bmjresp-2020-000623

Ejemplares similares

Efficacy of convalescent plasma for treatment of COVID-19 in Uganda
por: Kirenga, Bruce, et al.
Publicado: (2021)

Impact of corticosteroids in hospitalised COVID-19 patients
por: Ho, Kam Sing, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on non-COVID-19 community-acquired pneumonia: a retrospective cohort study
por: Lee, Terry, et al.
Publicado: (2023)

Symptomatic, biochemical and radiographic recovery in patients with COVID-19
por: Mallia, Patrick, et al.
Publicado: (2021)

Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score
por: Berenguer, Juan, et al.
Publicado: (2021)

Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA
por: Bradley, Patrick, et al.
Publicado: (2020)

Improving the early identification of COVID-19 pneumonia: a narrative review
por: Goyal, Daniel, et al.
Publicado: (2021)

C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 ‘LIVE-AIR’ trial
por: Temesgen, Zelalem, et al.
Publicado: (2023)

Rationale for azithromycin in COVID-19: an overview of existing evidence
por: Gyselinck, Iwein, et al.
Publicado: (2021)

Frailty assessment for COVID-19 follow-up: a prospective cohort study
por: Müller, Ilena, et al.
Publicado: (2022)

Association of smoking status with outcomes in hospitalised patients with COVID-19
por: Adrish, Muhammad, et al.
Publicado: (2020)

Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis
por: Dawson, Camilla, et al.
Publicado: (2023)

TMEM16A/ANO1 calcium-activated chloride channel as a novel target for the treatment of human respiratory syncytial virus infection
por: Pearson, Hayley, et al.
Publicado: (2021)

Low utilisation of bronchoscopy to assess COVID-19 respiratory infection: a multicenter experience
por: Mahmood, Kamran, et al.
Publicado: (2021)

Comparison of prognostic scores for inpatients with COVID-19: a retrospective monocentric cohort study
por: Martin, Jeremy, et al.
Publicado: (2022)

Shift work is associated with positive COVID-19 status in hospitalised patients
por: Maidstone, Robert, et al.
Publicado: (2021)

Large scale clinical trials: lessons from the COVID-19 pandemic
por: Horsley, Alex R, et al.
Publicado: (2022)

Venous thromboembolism in patients with COVID-19 and correlation with D-dimers: a single-centre experience
por: Khan, Muhammad Ziaullah, et al.
Publicado: (2020)

Clinical features of COVID-19 patients with rebound phenomenon after corticosteroid therapy
por: Murakami, Koji, et al.
Publicado: (2022)

Coronary artery calcium score may be a novel predictor of COVID-19 prognosis: a retrospective study
por: Takeshita, Yuichiro, et al.
Publicado: (2021)

Analyses of abdominal adiposity and metabolic syndrome as risk factors for respiratory distress in COVID-19
por: van Zelst, Cathelijne M, et al.
Publicado: (2020)

Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19
por: Saris, Anno, et al.
Publicado: (2021)

CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation
por: Ashish, Abdul, et al.
Publicado: (2020)

Clinical characteristics and outcomes of adult patients admitted with COVID-19 in East London: a retrospective cohort analysis
por: Cheng, Daryl, et al.
Publicado: (2021)

Respiratory function and CT abnormalities among survivors of COVID-19 pneumonia: a nationwide follow-up study
por: Axelsson, Gisli Thor, et al.
Publicado: (2022)

Predicting death from COVID-19 using pre-existing conditions: implications for vaccination triage
por: Xiao, Shujie, et al.
Publicado: (2021)

Association between influenza vaccination and hospitalisation or all-cause mortality in people with COVID-19: a retrospective cohort study
por: Wilcox, Christopher R, et al.
Publicado: (2021)

Dysfunctional breathing symptoms, functional impact and quality of life in patients with long COVID-19: a prospective case series
por: Genecand, Léon, et al.
Publicado: (2023)

Experiences of nurses caring for respiratory patients during the first wave of the COVID-19 pandemic: an online survey study
por: Roberts, Nicola J, et al.
Publicado: (2021)

Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol
por: Nakagawara, Kensuke, et al.
Publicado: (2021)

Ethnicity and risk of death in patients hospitalised for COVID-19 infection in the UK: an observational cohort study in an urban catchment area
por: Sapey, Elizabeth, et al.
Publicado: (2020)

Serum KL-6 levels predict clinical outcomes and are associated with MUC1 polymorphism in Japanese patients with COVID-19
por: Azekawa, Shuhei, et al.
Publicado: (2023)

TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial
por: Ware, Lorraine B, et al.
Publicado: (2023)

Risk factors of mortality among patients hospitalised with COVID-19 in a critical care or hospital care unit: analysis of the French national medicoadministrative database
por: Ouattara, Eric, et al.
Publicado: (2021)

Evaluation of the Post-COVID-19 Functional Status (PCFS) Scale in a cohort of patients recovering from hypoxemic SARS-CoV-2 pneumonia
por: Benkalfate, Naïla, et al.
Publicado: (2022)

COVID-19 admission risk tools should include multiethnic age structures, multimorbidity and deprivation metrics for air pollution, household overcrowding, housing quality and adult skills
por: Soltan, Marina A, et al.
Publicado: (2021)

Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells
por: Yamada, Souichi, et al.
Publicado: (2021)

Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases
por: Harboe, Zitta Barrella, et al.
Publicado: (2022)

Vimentin knockout results in increased expression of sub-endothelial basement membrane components and carotid stiffness in mice
por: Langlois, Benoit, et al.
Publicado: (2017)

Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator–IL-6–antimicrobial–repair pathway
por: Saint-Criq, Vinciane, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0oquagqg21qe0mo6kum1lttmhl